|
Shukra Pharmaceuticals Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
1396.40 Cr.
|
P/BV
|
16.21
|
Book Value (Rs.)
|
1.97
|
|
52 Week High/Low (Rs.)
|
65/12
|
FV/ML
|
1/1
|
P/E(X)
|
145.88
|
|
Bookclosure
|
18/09/2025
|
EPS (Rs.)
|
0.22
|
Div Yield (%)
|
0.03
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 39.13 | 5.88 | 10.58 |
| Total Income From Operations | 39.13 | 5.88 | 10.58 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 3.20 | 10.81 | 3.78 |
| Increase/Decrease in Stocks | 3.93 | -8.80 | 0.18 |
| Employees Cost | 2.65 | 2.19 | 1.55 |
| Depreciation | 0.84 | 0.81 | 0.70 |
| Other Expenses | 2.22 | 2.10 | 1.14 |
| Total Expenses | 12.84 | 7.11 | 7.34 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 26.30 | -1.23 | 3.24 |
| Other Income | 0.82 | 1.71 | 1.01 |
| P/L Before Interest, Excpt. Items & Tax | 27.11 | 0.48 | 4.25 |
| Interest | 0.28 | 0.29 | 0.15 |
| P/L Before Exceptional Items & Tax | 26.83 | 0.20 | 4.09 |
| P/L Before Tax | 26.83 | 0.20 | 4.09 |
| Tax | 6.47 | -2.18 | 0.93 |
| P/L After Tax from Ordinary Activities | 20.36 | 2.38 | 3.16 |
| Net Profit/Loss For the Period | 20.36 | 2.38 | 3.16 |
| Net P/L After Minority Interest & Share Of Associates | 20.36 | 2.38 | 3.16 |
| | | | |
| Equity Share Capital | 43.79 | 43.79 | 43.79 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | 0.47 | 0.05 | 0.72 |
| Diluted EPS (Rs.) | 0.47 | 0.05 | 0.72 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | 0.47 | 0.05 | 0.72 |
| Diluted EPS (Rs.) | 0.47 | 0.05 | 0.72 |
| | | | |
| PBITOE Margin (%) | 67.19 | -20.91 | 30.60 |
| PBTE Margin (%) | 68.56 | 3.37 | 38.68 |
| PBT Margin (%) | 68.56 | 3.37 | 38.68 |
| PAT Margin (%) | 52.03 | 40.46 | 29.89 |
| PAT After MI And SOA Margin (%) | 52.03 | 40.46 | 29.89 |
